Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome
In conclusion, in ACS patients, type 2 DM enhances the risk of MACE regardless of the DM cluster, whereas the propensity to bleeding related to DM seems confined to insulin-treated patients.
Source: Internal and Emergency Medicine - Category: Emergency Medicine Source Type: research
More News: Aspirin | Bleeding | Cardiology | Cardiovascular | Clopidogrel | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Emergency Medicine | Endocrinology | Heart | Insulin | Italy Health | Plavix | Study